In addition, melittin has been found to encourage TRAIL-resistant HCC cells to TRAIL-induced cell death, probably through stimulating the CAMKII-TAK1-JNK/p38 route and blocking the IKK-NFB signaling. This evidence concerns the gene MAPK8 and hepatocellular carcinoma.